Literature DB >> 2191887

Intrinsic cytotoxicity of natural killer cells to pancreatic islets in vitro.

N Nakamura1, B A Woda, A Tafuri, D L Greiner, C W Reynolds, J Ortaldo, W Chick, E S Handler, J P Mordes, A A Rossini.   

Abstract

BB rats develop spontaneous autoimmune insulin-dependent diabetes mellitus that is similar to human insulin-dependent diabetes. In this study, we used an in vitro islet cell cytotoxicity assay to study the possible role of natural killer (NK) cells and their soluble effector molecules in this disorder. First, the results demonstrated that in vivo treatment of acutely diabetic BB rats with anti-asialogangliosideM1 (an NK cell antiserum) but not with anti-T-lymphocyte antibodies reduces spleen cell cytotoxic activity to islets in vitro. Flow microfluorometry (FMF)-sorting experiments were then used to confirm that the splenic cytotoxic effector cell in acutely diabetic BB rats is a CD8+/CD5- NK cell. Further analysis demonstrated that both FMF-sorted NK cell populations from Wistar-Furth rats and unfractionated spleen cells from athymic nu/nu rats with high intrinsic NK cell activity also exhibit high islet cell cytotoxic activity in vitro. Finally, we found that the kinetics and differential cytotoxic activity of NK cells toward islets in vitro could be mimicked by NK cell culture supernatants containing high levels of NK cytotoxic factor (NKCF). The islet cytotoxic activity of these culture supernatants was specifically inhibited by the addition of anti-NKCF monoclonal antibody. These results demonstrate that NK cells from diabetic and nondiabetic rats are cytotoxic to islet cells in vitro. They further suggest that this cytotoxic effect may be mediated in part through the production and release of soluble factors such as NKCF.

Entities:  

Mesh:

Year:  1990        PMID: 2191887     DOI: 10.2337/diab.39.7.836

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  9 in total

Review 1.  Innate immunity and the pathogenesis of type 1 diabetes.

Authors:  Fabio Arturo Grieco; Francesco Vendrame; Isabella Spagnuolo; Francesco Dotta
Journal:  Semin Immunopathol       Date:  2010-04-10       Impact factor: 9.623

2.  Hyperglycemia-induced proliferation of adult human beta cells engrafted into spontaneously diabetic immunodeficient NOD-Rag1null IL2rγnull Ins2Akita mice.

Authors:  Philip Diiorio; Agata Jurczyk; Chaoxing Yang; Waldemar J Racki; Michael A Brehm; Mark A Atkinson; Alvin C Powers; Leonard D Shultz; Dale L Greiner; Rita Bortell
Journal:  Pancreas       Date:  2011-10       Impact factor: 3.327

3.  The activating receptor NKp46 is essential for the development of type 1 diabetes.

Authors:  Chamutal Gur; Angel Porgador; Moran Elboim; Roi Gazit; Saar Mizrahi; Noam Stern-Ginossar; Hagit Achdout; Hormas Ghadially; Yuval Dor; Tomer Nir; Victoria Doviner; Oren Hershkovitz; Michal Mendelson; Yaakov Naparstek; Ofer Mandelboim
Journal:  Nat Immunol       Date:  2009-12-20       Impact factor: 25.606

Review 4.  The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy.

Authors:  Chris Fraker; Allison L Bayer
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

5.  Natural killer cell depletion and diabetes mellitus in the BB/Wor rat (revisited).

Authors:  K Ellerman; M Wrobleski; A Rabinovitch; A Like
Journal:  Diabetologia       Date:  1993-07       Impact factor: 10.122

6.  A new immunodeficient hyperglycaemic mouse model based on the Ins2Akita mutation for analyses of human islet and beta stem and progenitor cell function.

Authors:  T Pearson; L D Shultz; J Lief; L Burzenski; B Gott; T Chase; O Foreman; A A Rossini; R Bottino; M Trucco; D L Greiner
Journal:  Diabetologia       Date:  2008-06-19       Impact factor: 10.122

7.  Mucosal tolerance to prevent type 1 diabetes: can the outcome be improved in humans?

Authors:  Arno Hanninen; Leonard C Harrison
Journal:  Rev Diabet Stud       Date:  2004-11-10

8.  Prevention of diabetes in BB/Wor rats by intrathymic islet injection.

Authors:  S B Koevary; M Blomberg
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

Review 9.  The role of natural cytotoxicity receptors in various pathologies: emphasis on type I diabetes.

Authors:  Jonatan Enk; Ofer Mandelboim
Journal:  Front Immunol       Date:  2014-01-20       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.